The in vitro effects of antibiotics on cell viability and gene expression of equine bone marrow-derived mesenchymal stromal cells

Equine Veterinary Journal

Volumn 44, Issue 3, 2012, Pages 355-360

  Parker, R A ^a   Clegg, P D ^b   Taylor, S E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Antibiotics; Cell viability; Equine; Gene expression; Horse; Mesenchymal stromal cells

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HORSE; MESENCHYMAL STROMA CELL; METABOLISM;

ANIMALS; ANTI-BACTERIAL AGENTS; BONE MARROW CELLS; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION REGULATION; HORSES; MESENCHYMAL STROMAL CELLS;

EQUIDAE;

EID: 84859438815     PISSN: 04251644     EISSN: 20423306     Source Type: Journal    
DOI: 10.1111/j.2042-3306.2011.00437.x     Document Type: Article

References (46)

1. Andersen, C.L., Jensen, J.L. and Orntoft, T.F. (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64, 5245-5250.
2. Arnoczky, S.P., Lavagnino, M., Gardner, K.L., Tian, T., Vaupel, Z.M. and Stick, J.A. (2004) In vitro effects of oxytetracycline on matrix metalloproteinase-1 mRNA expression and on collagen gel contraction by cultured myofibroblasts obtained from the accessory ligament of foals. Am. J. vet. Res. 65, 491-496.
3. Atilla, A., Boothe, H.W., Tollett, M., Duran, S., Diaz, D.C., Sofge, J. and Boothe, D.M. (2010) In vitro elution of amikacin and vancomycin from impregnated plaster of Paris beads. Vet. Surg. 39, 715-721.
4. Bae, W.Y., Kim, L.S., Hur, D.Y., Jeong, S.W. and Kim, J.R. (2008) Secondary apoptosis of spiral ganglion cells induced by aminoglycoside: Fas-Fas ligand signaling pathway. Laryngoscope 118, 1659-1668.
5. Beluche, L.A., Bertone, A.L., Anderson, D.E., Kohn, C.W. and Weisbrode, S.E. (1999) In vitro dose-dependent effects of enrofloxacin on equine articular cartilage. Am. J. vet. Res. 60, 577-582.
6. Border, W.A., Noble, N.A., Yamamoto, T., Harper, J.R., Yamaguchi, Y., Pierschbacher, M.D. and Ruoslahti, E. (1992) Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360, 361-364.
7. Brown, S.A. (1996) Fluoroquinolones in animal health. J. vet. Pharmacol. Therap. 19, 1-14.
8. Butt, T.D., Bailey, J.V., Dowling, P.M. and Fretz, P.B. (2001) Comparison of 2 techniques for regional antibiotic delivery to the equine forelimb: intraosseous perfusion vs. intravenous perfusion. Can. vet. J. 42, 617-622.
9. Byth, H.A., McHunu, B.I., Dubery, I.A. and Bornman, L. (2001) Assessment of a simple, non-toxic Alamar blue cell survival assay to monitor tomato cell viability. Phytochem. Anal. 12, 340-346.
10. Chang, Y., Goldberg, V.M. and Caplan, A.I. (2006) Toxic effects of gentamicin on marrow-derived human mesenchymal stem cells. Clin. orthop. Rel. Res. 452, 242-249.
11. Clements, D.N., Vaughan-Thomas, A., Peansukmanee, S., Carter, S.D., Innes, J.F., Ollier, W.E. and Clegg, P.D. (2006) Assessment of the use of RNA quality metrics for the screening of articular cartilage specimens from clinically normal dogs and dogs with osteoarthritis. Am. J. vet. Res. 67, 1438-1444.
12. Cruz, A.M., Rubio-Martinez, L. and Dowling, T. (2006) New antimicrobials, systemic distribution, and local methods of antimicrobial delivery in horses. Vet. Clin. N. Am.: Equine Pract. 22, 297-322, vii-viii.
13. Davenport, C.L., Boston, R.C. and Richardson, D.W. (2001) Effects of enrofloxacin and magnesium deficiency on matrix metabolism in equine articular cartilage. Am. J. vet. Res. 62, 160-166.
14. Degterev, A. and Yuan, J. (2008) Expansion and evolution of cell death programmes. Nat. Rev. 9, 378-390.
15. Egerbacher, M., Edinger, J. and Tschulenk, W. (2001) Effects of enrofloxacin and ciprofloxacin hydrochloride on canine and equine chondrocytes in culture. Am. J. vet. Res. 62, 704-708.
16. Fortier, L.A., Motta, T., Greenwald, R.A., Divers, T.J. and Mayr, K.G. (2010a) Synoviocytes are more sensitive than cartilage to the effects of minocycline and doxycycline on IL-1alpha and MMP-13-induced catabolic gene responses. J. orthop. Res. 28, 522-528.
17. Fortier, L.A., Potter, H.G., Rickey, E.J., Schnabel, L.V., Foo, L.F., Chong, L.R., Stokol, T., Cheetham, J. and Nixon, A.J. (2010b) Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J. Bone Joint Surg. 92, 1927-1937.
18. Giguere, S., Prescott, J.F., Baggot, J.D., Walker, R.D. and Dowling, P.M. (2006) Antimicrobial Therapy in Veterinary Medicine, 4th edn., Blackwell Publishing, Oxford.
19. Holcombe, S.J., Schneider, R.K., Bramlage, L.R. and Embertson, R.M. (1997) Use of antibiotic-impregnated polymethyl methacrylate in horses with open or infected fractures or joints: 19 cases (1987-1995). J. Am. vet. med. Ass. 211, 889-893.
20. Isefuku, S., Joyner, C.J. and Simpson, A.H. (2003) Gentamicin may have an adverse effect on osteogenesis. J. Orthop. Trauma. 17, 212-216.
21. Kasashima, Y., Ueno, T., Tomita, A., Goodship, A.E. and Smith, R.K.W. (2011) Optimisation fo bone marrow aspiration from the equine sternum for the safe recovery of mesenchymal stem cells. Equine vet. J. 43, 288-294.
22. Kettner, N.U., Parker, J.E. and Watrous, B.J. (2003) Intraosseous regional perfusion for treatment of septic physitis in a two-week-old foal. J. Am. vet. med. Ass. 222, 346-350, 316.
23. Klemm, K.W. (1993) Antibiotic bead chains. Clin. orthop. Rel. Res. 295, 63-76.
24. Mattson, S., Boure, L., Pearce, S., Hurtig, M., Burger, J. and Black, W. (2004) Intraosseous gentamicin perfusion of the distal metacarpus in standing horses. Vet. Surg. 33, 180-186.
25. Mattson, S.E., Pearce, S.G., Boure, L.P., Dobson, H., Hurtig, M.B. and Black, W.D. (2005) Comparison of intraosseous and intravenous infusion of technetium Tc 99m pertechnate in the distal portion of forelimbs in standing horses by use of scintigraphic imaging. Am. J. vet. Res. 66, 1267-1272.
26. Miclau, T., Edin, M., Lester, G., Lindsey, R. and Dahners, L. (1995) Bone toxicity of locally applied aminoglycosides. J. Orthop. Trauma. 9, 401-406.
27. Nakayama, G.R., Caton, M.C., Nova, M.P. and Parandoosh, Z. (1997) Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J. Immunol. Methods 204, 205-208.
28. Ozaki, N., Matheis, K.A., Gamber, M., Feidl, T., Nolte, T., Kalkuhl, A. and Deschl, U. (2010) Identification of genes involved in gentamicin-induced nephrotoxicity in rats - a toxicogenomic investigation. Expt. Toxicol. Pathol. 62, 555-566.
29. Parker, R.A., Bladon, B.M., McGovern, K. and Smith, K.C. (2010) Osteomyelitis and osteonecrosis after intraosseous perfusion with gentamicin. Vet. Surg. 39, 644-648.
30. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45.
31. Pfaffl, M.W., Tichopad, A., Prgomet, C. and Neuvians, T.P. (2004) Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper - Excel-based tool using pair-wise correlations. Biotechnol. Lett. 26, 509-515.
32. Porter, A.G. and Janicke, R.U. (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6, 99-104.
33. Reno, C., Marchuk, L., Sciore, P., Frank, C.B. and Hart, D.A. (1997) Rapid isolation of total RNA from small samples of hypocellular, dense connective tissues. Biotechniques 22, 1082-1086.
34. Rubio-Martinez, L.M. and Cruz, A.M. (2006) Antimicrobial regional limb perfusion in horses. J. Am. vet. med. Ass. 228, 706-712, 655.
35. Rubio-Martinez, L., Lopez-Sanroman, J., Cruz, A.M., Santos, M. and San Roman, F. (2005) Medullary plasma pharmacokinetics of vancomycin after intravenous and intraosseous perfusion of the proximal phalanx in horses. Vet. Surg. 34, 618-624.
36. Ruoslahti, E. and Yamaguchi, Y. (1991) Proteoglycans as modulators of growth factor activities. Cell 64, 867-869.
37. Santschi, E.M. and McGarvey, L. (2003) In vitro elution of gentamicin from Plaster of Paris beads. Vet. Surg. 32, 128-133.
38. Schreer, A., Tinson, C., Sherry, J.P. and Schirmer, K. (2005) Application of Alamar blue/5-carboxyfluorescein diacetate acetoxymethyl ester as a noninvasive cell viability assay in primary hepatocytes from rainbow trout. Analyt. Biochem. 344, 76-85.
39. Smith, R.K. (2006) Stem cell technology in equine tendon and ligament injuries. Vet. Rec. 158, 140.
40. Smith, R.K. (2008) Mesenchymal stem cell therapy for equine tendinopathy. Disabil. Rehabil. 30, 1752-1758.
41. Taylor, S.E., Smith, R.K. and Clegg, P.D. (2007) Mesenchymal stem cell therapy in equine musculoskeletal disease: scientific fact or clinical fiction? Equine vet. J. 39, 172-180.
42. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A. and Speleman, F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, 7. RESEARCH0034.
43. Von Hoff, D.D., Kuhn, J.G., Burris, H.A., 3rd and Miller, L.J. (2008) Does intraosseous equal intravenous? A pharmacokinetic study. Am. J. emerg. Med. 26, 31-38.
44. Yoo, J.U. and Johnstone, B. (1998) The role of osteochondral progenitor cells in fracture repair. Clin. orthop. Rel. Res., Suppl 355, S73-S81.
45. Yoon, J.H., Brooks, R.L., Jr, Khan, A., Pan, H., Bryan, J., Zhang, J., Budsberg, S.C., Mueller, P.O. and Halper, J. (2004) The effect of enrofloxacin on cell proliferation and proteoglycans in horse tendon cells. Cell Biol. Toxicol. 20, 41-54.
46. Youle, R.J. and Strasser, A. (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. 9, 47-59.